Your browser doesn't support javascript.
loading
Drug-Induced Anaphylaxis: An Update on Epidemiology and Risk Factors.
Regateiro, Frederico S; Marques, Maria Luís; Gomes, Eva Rebelo.
Afiliação
  • Regateiro FS; Allergy and Clinical Immunology Unit, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, regateiro@gmail.com.
  • Marques ML; Institute of Immunology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal, regateiro@gmail.com.
  • Gomes ER; Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal, regateiro@gmail.com.
Int Arch Allergy Immunol ; 181(7): 481-487, 2020.
Article em En | MEDLINE | ID: mdl-32396909
ABSTRACT
Drug hypersensitivity is one of the most frequent causes of anaphylaxis, particularly in adults and in hospitalized patients. Drug-induced anaphylaxis (DIA) is also associated with more severe outcomes than other anaphylaxis triggers, and drugs are responsible for the majority of deaths due to anaphylaxis. We here review the current knowledge on the incidence, prevalence, drugs involved, mortality, and mortality risk factors for DIA. The incidence of both anaphylaxis and DIA seems to be increasing worldwide. Antibiotics and analgesics are the most frequently reported triggers of DIA. However, the importance of other drug groups should be taken into account, especially in particular settings (e.g., peri-operative and oncology). The identification of risk factors, geographical variables, and drugs associated with higher risk for DIA may improve the outcomes of this entity.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipersensibilidade a Drogas / Anafilaxia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hipersensibilidade a Drogas / Anafilaxia Idioma: En Ano de publicação: 2020 Tipo de documento: Article